AU2017295038B2 - 5-hydroxytryptamine 1B receptor-stimulating agent for skin and/or hair repair - Google Patents
5-hydroxytryptamine 1B receptor-stimulating agent for skin and/or hair repair Download PDFInfo
- Publication number
- AU2017295038B2 AU2017295038B2 AU2017295038A AU2017295038A AU2017295038B2 AU 2017295038 B2 AU2017295038 B2 AU 2017295038B2 AU 2017295038 A AU2017295038 A AU 2017295038A AU 2017295038 A AU2017295038 A AU 2017295038A AU 2017295038 B2 AU2017295038 B2 AU 2017295038B2
- Authority
- AU
- Australia
- Prior art keywords
- skin
- hair
- vortioxetine
- receptor
- hydroxytryptamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/884—Sequential application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IBPCT/IB2016/001136 | 2016-07-15 | ||
| IB2016001136 | 2016-07-15 | ||
| PCT/EP2017/067791 WO2018011382A1 (en) | 2016-07-15 | 2017-07-13 | 5-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2017295038A1 AU2017295038A1 (en) | 2019-01-24 |
| AU2017295038B2 true AU2017295038B2 (en) | 2022-09-22 |
Family
ID=56787641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017295038A Expired - Fee Related AU2017295038B2 (en) | 2016-07-15 | 2017-07-13 | 5-hydroxytryptamine 1B receptor-stimulating agent for skin and/or hair repair |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20190290641A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3484462B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019524723A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190038840A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110022869A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017295038B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019000706A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3030054A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX386989B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018011382A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3799873A1 (en) | 2015-07-17 | 2021-04-07 | Institut Pasteur | 5-hydroxytryptamine 1b receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiation |
| US11013830B2 (en) | 2015-11-20 | 2021-05-25 | Institut Pasteur | 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential |
| BR112020026099A2 (pt) * | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
| CA3158781A1 (en) * | 2019-10-23 | 2021-04-29 | Michael Wood | Methods of treating the symptoms of autism spectrum disorder |
| CN115919860B (zh) * | 2022-12-05 | 2023-11-10 | 中国药科大学 | 氟班色林在制备治疗雄激素脱发药物中的用途 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003029232A1 (en) * | 2001-10-04 | 2003-04-10 | H. Lundbeck A/S | Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| WO2007148341A2 (en) * | 2006-06-22 | 2007-12-27 | Ramot At Tel Aviv University Ltd. | Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| WO2008078353A1 (en) * | 2006-12-22 | 2008-07-03 | Medestea Internazionale S.P.A. | A novel use of antidepressant compounds and related compositions |
| WO2011048496A1 (en) * | 2009-10-23 | 2011-04-28 | Fortuderm, Ltd. | Triptans for the treatment of psoriasis |
| WO2014190063A1 (en) * | 2013-05-21 | 2014-11-27 | Wynberg Jason B | Methods for the treatment of premature ejaculation |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63203625A (ja) | 1987-02-19 | 1988-08-23 | Kao Corp | 5α−リダクタ−ゼ阻害剤 |
| FR2739553B1 (fr) | 1995-10-06 | 1998-01-02 | Oreal | Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
| FR2758263B1 (fr) * | 1997-01-16 | 1999-12-17 | Oreal | Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue |
| FR2778558B1 (fr) | 1998-05-12 | 2001-02-16 | Oreal | Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute |
| ES2147538B1 (es) | 1999-01-29 | 2001-04-01 | Revlon Consumer Prod Corp | Una locion capilar con propiedades mejoradas en su accion protectora del cabello y preventiva de su caida, y de reduccion de los efectos externos de la alopecia androgenetica y con ello de la caida del cabello. |
| JP3441665B2 (ja) | 1999-02-04 | 2003-09-02 | 株式会社資生堂 | (2−置換オキシフェニル)アルカンアミド誘導体及び養毛剤、皮膚外用剤 |
| US20060052405A1 (en) | 2000-07-19 | 2006-03-09 | Knowles W R | Hair loss prevention |
| FR2812192B1 (fr) | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
| ATE316387T1 (de) * | 2000-09-22 | 2006-02-15 | Perlei Medical Produkte Gmbh | Verwendung von antifibrinolytika für die präparation und herstellung von tupfern, kompressen oder pflaster |
| ES2267945T3 (es) | 2001-05-31 | 2007-03-16 | Pfizer Products Inc. | Uso medico de compuestos tiromimeticos para tratar la perdida del cabello y composiciones. |
| EP1435899B1 (en) | 2001-09-28 | 2009-03-11 | LG Household & Health Care Ltd. | A composition for promoting hair growth |
| US6860042B2 (en) | 2002-07-19 | 2005-03-01 | Walker-Dawson Interests, Inc. | Excavation system employing a jet pump |
| US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| ATE407724T1 (de) | 2002-11-12 | 2008-09-15 | Warner Lambert Co | Methode zur stimulierung von haarwuchs auf der basis von benzopyranen |
| CA2511089A1 (en) | 2003-01-17 | 2004-08-05 | Warner-Lambert Company Llc | Androgen receptor antagonists |
| ES2436524T3 (es) | 2003-05-22 | 2014-01-02 | Nerviano Medical Sciences S.R.L. | Derivados de pirazolo-quinazolina, procedimiento para su preparación y su uso como inhibidores de cinasas |
| US20050118282A1 (en) | 2003-09-16 | 2005-06-02 | Aphios Corporation | Compositions and methods for inhibiting 5-alpha reductase |
| AR041407A1 (es) | 2003-09-26 | 2005-05-18 | Nestor Alberto Kerner | Oligonucleotidos antiandrogenos utilizables en el tratamiento de patologias dermatologicas relacionadas con el metabolismo de los androgenos, sus composiciones farmaceuticas y sus usos y metodos de tratamiento |
| US20060009430A1 (en) | 2004-07-01 | 2006-01-12 | Kelly Gregory J | Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone |
| MXPA06015169A (es) | 2004-07-08 | 2007-08-21 | Warner Lambert Co | Moduladores de androgenos. |
| DE202006007482U1 (de) | 2006-05-10 | 2006-07-20 | Sentner, Thomas | Leuchtmöbel |
| MY150647A (en) * | 2006-06-16 | 2014-02-14 | Lundbeck & Co As H | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| FR2903984B1 (fr) | 2006-07-24 | 2008-10-03 | Genfit Sa | Derives d'imidazolones substitues, preparation et utilisations |
| WO2008084286A2 (en) * | 2006-10-25 | 2008-07-17 | Arterial Remodeling Technologies, S.A. | Method for expansion and deployment of polymeric structures including stents |
| US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
| ITTO20060918A1 (it) * | 2006-12-22 | 2008-06-23 | Chiara Cesano | Composizione cosmetica e farmaceutica e mezzo di coltura per la rigenerazione del tessuto cutaneo, e relativi usi |
| ES2622138T3 (es) | 2010-06-23 | 2017-07-05 | Hanmi Science Co., Ltd. | Nuevos derivados de pirimidina condensados para la inhibición de la actividad tirosina quinasa |
| CN104736176B (zh) * | 2012-08-24 | 2017-10-13 | 英特格拉斯疗法有限公司 | 用于增强治疗剂透皮递送的化学组合物和方法 |
| US9399039B1 (en) * | 2015-06-30 | 2016-07-26 | University Of South Florida | Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use |
-
2017
- 2017-07-13 BR BR112019000706A patent/BR112019000706A8/pt not_active IP Right Cessation
- 2017-07-13 KR KR1020197004019A patent/KR20190038840A/ko not_active Ceased
- 2017-07-13 WO PCT/EP2017/067791 patent/WO2018011382A1/en not_active Ceased
- 2017-07-13 EP EP17742997.4A patent/EP3484462B1/en active Active
- 2017-07-13 AU AU2017295038A patent/AU2017295038B2/en not_active Expired - Fee Related
- 2017-07-13 CN CN201780055993.4A patent/CN110022869A/zh active Pending
- 2017-07-13 US US16/316,557 patent/US20190290641A1/en not_active Abandoned
- 2017-07-13 CA CA3030054A patent/CA3030054A1/en active Pending
- 2017-07-13 MX MX2019000600A patent/MX386989B/es unknown
- 2017-07-13 JP JP2019501427A patent/JP2019524723A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003029232A1 (en) * | 2001-10-04 | 2003-04-10 | H. Lundbeck A/S | Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| WO2007148341A2 (en) * | 2006-06-22 | 2007-12-27 | Ramot At Tel Aviv University Ltd. | Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| WO2008078353A1 (en) * | 2006-12-22 | 2008-07-03 | Medestea Internazionale S.P.A. | A novel use of antidepressant compounds and related compositions |
| WO2011048496A1 (en) * | 2009-10-23 | 2011-04-28 | Fortuderm, Ltd. | Triptans for the treatment of psoriasis |
| WO2014190063A1 (en) * | 2013-05-21 | 2014-11-27 | Wynberg Jason B | Methods for the treatment of premature ejaculation |
Non-Patent Citations (2)
| Title |
|---|
| ALEX MALININ, BENJAMIN OSHRINE, VICTOR SEREBRUANY: "Treatment with selective serotonin reuptake inhibitors for enhancing wound healing", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH., US, vol. 63, no. 1, 1 January 2004 (2004-01-01), US , pages 103 - 109, XP055348687, ISSN: 0306-9877, DOI: 10.1016/j.mehy.2003.10.021 * |
| NGUYEN: JOURNAL OF INVESTIGATIVE DERMATOLOGY, S133 PUBLISHED IN ISSUE: MAY 2016, 1 May 2016 (2016-05-01), XP055348757, Retrieved from the Internet [retrieved on 20170222] * |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019000706A8 (pt) | 2022-12-06 |
| EP3484462B1 (en) | 2022-12-14 |
| KR20190038840A (ko) | 2019-04-09 |
| JP2019524723A (ja) | 2019-09-05 |
| EP3484462A1 (en) | 2019-05-22 |
| AU2017295038A1 (en) | 2019-01-24 |
| CA3030054A1 (en) | 2018-01-18 |
| US20190290641A1 (en) | 2019-09-26 |
| MX386989B (es) | 2025-03-19 |
| BR112019000706A2 (pt) | 2019-05-07 |
| WO2018011382A1 (en) | 2018-01-18 |
| MX2019000600A (es) | 2019-06-13 |
| CN110022869A (zh) | 2019-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3484462B1 (en) | 5-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repair | |
| JP2001510154A (ja) | カッパアゴニスト化合物、製剤、ならびにそれらによる掻痒の予防法および治療法 | |
| JP7159302B2 (ja) | 線維性疾患の治療のための方法 | |
| CA2761732C (en) | Composition for preventing hair loss or for stimulating hair growth | |
| US20210330863A1 (en) | 5-hydroxytryptamine 1b receptor-stimulating agent for enhancing in vivo engraftment potential | |
| CN101903009B (zh) | 含有脱硫生物素及其衍生物的局部组合物和治疗皮肤的方法 | |
| EP3573957A1 (en) | Compositions and methods for blocking sodium channels | |
| JP6116679B2 (ja) | (1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミンおよび抗けいれん剤を含む医薬組成物 | |
| JPWO2003066100A1 (ja) | 発毛促進剤、経皮適用製剤及び発毛促進方法 | |
| CA2339996C (en) | Method for treating hot flashes in humans | |
| AU2021295580B2 (en) | Use of compounds as self-tanning substances and tanning compositions thereof | |
| TW201424764A (zh) | 膠原蛋白刺激物及其於處理皮膚之用途 | |
| AU2007238816B2 (en) | Methods for modulating formation and progression of cellulite | |
| JP2025071027A (ja) | チモールエステル系化合物を含む皮膚老化の予防または改善用組成物 | |
| KR20130028693A (ko) | Pde5 억제제를 함유하는 피부 주름 개선용 조성물 | |
| KR102723050B1 (ko) | Bcl-2 억제제를 포함하는 항노화 및 피부 미백용 조성물 | |
| JP2020502279A (ja) | 色素沈着過剰障害の処置方法 | |
| HK1256597A1 (zh) | 含有细胞老化抑制剂作为有效成分的皮肤皱纹改善用及皮肤损伤炎症疾病治疗用组合物 | |
| MX2007002790A (es) | Combinacion de un agonista del receptor 5-hidroxitriptamina (i) y un ligando alfa-2-delta para el tratamiento de migrana. | |
| KR101629540B1 (ko) | 신규 벤조 이미다조 이미다졸 유도체 및 이를 유효성분으로 함유하는 피부 미백용 조성물 | |
| KR20230154641A (ko) | 설포라판을 유효성분으로 포함하는 피부 질환의 예방, 개선 또는 치료용 조성물 | |
| JP2025041554A (ja) | チモールエステル系化合物を含む皮膚活力増強用組成物 | |
| JP2025106164A (ja) | チモールエステル系化合物を含む皮膚保護用組成物 | |
| TW202509038A (zh) | 異穿心蓮內酯(isoandrographolide)類似物及使用其之治療方法 | |
| WO2019021287A1 (en) | TREATMENT OF SKIN DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: CENTRE HOSPITALIER SAINTE ANNE PARIS Free format text: FORMER APPLICANT(S): INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; CENTRE HOSPITALIER SAINTE ANNE PARIS Owner name: INSTITUT PASTEUR Free format text: FORMER APPLICANT(S): INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; CENTRE HOSPITALIER SAINTE ANNE PARIS Owner name: UNIVERSITE PARIS CITE Free format text: FORMER APPLICANT(S): INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; CENTRE HOSPITALIER SAINTE ANNE PARIS |
|
| MK25 | Application lapsed reg. 22.2i(2) - failure to pay acceptance fee |